0000899243-16-022931.txt : 20160615 0000899243-16-022931.hdr.sgml : 20160615 20160615161521 ACCESSION NUMBER: 0000899243-16-022931 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160614 FILED AS OF DATE: 20160615 DATE AS OF CHANGE: 20160615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freed Martin I CENTRAL INDEX KEY: 0001676653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 161715437 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-14 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001676653 Freed Martin I C/O DICERNA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 1 0 0 0 Employee Stock Option (Right to Buy) 3.26 2016-06-14 4 A 0 25000 0.00 A 2026-06-14 Common Stock 25000 25000 D The option vests as to one-third of the underlying shares on June 14, 2017 and as to the remaining two-thirds of the shares in eight quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each such date. /s/ Michael Todisco, attorney-in-fact 2016-06-15